Yahoo Finance

InterVene Completes First 30 Cases Using the Recana® Thrombectomy Catheter System, Plans for Broader Commercial Launch

REDWOOD CITY, Calif., April 07, 2026--(BUSINESS WIRE)--InterVene, Inc., a privately held medical device company advancing interventional care for venous disease, today announced the successful ...
eSchool News

Intervene K-12 Receives $150,000 Grant From National Nonprofit Accelerate To Make High-Impact Tutoring Sustainable And Cost-Effective

Intervene K-12 uses evidence-based lessons that are designed especially for Intervene K-12 scholars to meet them where they are. These lessons are leveraged using high-impact, online tutoring within ...
Business Wire

InterVene Receives FDA 510(k) Clearance for Recana®, the First Fully Integrated Thrombectomy System for Venous In-Stent Restenosis and Native Vessel Obstructions

REDWOOD CITY, Calif.--(BUSINESS WIRE)--InterVene, Inc., a privately held medical device company pioneering interventional devices for venous occlusions, today announced it received 510(k) clearance ...
Business Wire

InterVene’s BlueLeaf Endovenous Valve Formation (EVF) System Granted Breakthrough Device Designation by the FDA

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--InterVene Inc. announced today that it has received Breakthrough Device Designation by the FDA for the company’s BlueLeaf ® Endovenous Valve Formation ...